ARA-290 – 10 mg

Rated 4.00 out of 5 based on 1 customer rating
(1 customer review)

Short Description

ARA-290 is a research peptide supplied in a 10mg lyophilized format for laboratory and analytical research purposes only. Commonly studied for its selective tissue-protective properties, ARA-290 is widely used in peptide-related scientific investigations and experimental research settings.

Long Description

ARA-290 – 10mg Research Peptide

ARA-290 is a synthetic peptide commonly researched for its potential role in cellular protection and inflammation-related studies. This peptide is supplied as a high-purity lyophilized powder in a secure 10mg vial intended strictly for laboratory research and analytical applications.

Researchers are increasingly interested in ARA-290 due to its selective interaction with specific receptor pathways associated with tissue protection and experimental recovery studies. It has become a valuable compound in peptide research environments focused on advanced biological investigations.

At Bio Peptide Planet, we prioritize product quality, consistency, and reliable sourcing to support professional research standards. Every vial is packaged carefully to maintain stability and research integrity.

Product Features

  • High-Purity Research Peptide
  • 10mg Lyophilized Powder
  • Secure & Professional Packaging
  • Intended for Laboratory Research Only
  • Quality-Focused Handling Standards
  • Suitable for Analytical & Scientific Studies

Storage Information

Store in a cool, dry place away from direct sunlight. Refrigeration is recommended for long-term storage after opening or reconstitution according to research protocols.

1 review for ARA-290 – 10 mg

  1. Rated 4 out of 5

    williamsebastian077@gmail.com

    ⭐⭐⭐⭐⭐
    “I’ve ordered from several suppliers before, but Bio Peptides Planet stands out for its reliability and quality. Great customer support, fast delivery, and products that meet high standards. Five stars all the way!”

Add a review

Your email address will not be published. Required fields are marked *

Scroll to Top